Minerva Neurosciences Stock Current Valuation
| NERV Stock | USD 2.26 0.00 0.00% |
Valuation analysis of Minerva Neurosciences helps investors to measure Minerva Neurosciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to climb to about 127.3 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (3.93) in 2024. Fundamental drivers impacting Minerva Neurosciences' valuation include:
Price Book 2.6783 | Enterprise Value -11.5 M | Enterprise Value Ebitda 2.6004 | Price Sales 1.868 | Forward PE 11.2108 |
Undervalued
Today
Please note that Minerva Neurosciences' price fluctuation is moderately volatile at this time. Calculation of the real value of Minerva Neurosciences is based on 3 months time horizon. Increasing Minerva Neurosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Minerva stock is determined by what a typical buyer is willing to pay for full or partial control of Minerva Neurosciences. Since Minerva Neurosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Minerva Stock. However, Minerva Neurosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.26 | Real 4.29 | Target 11.0 | Hype 2.16 | Naive 2.24 |
The intrinsic value of Minerva Neurosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Minerva Neurosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Minerva Neurosciences helps investors to forecast how Minerva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Minerva Neurosciences more accurately as focusing exclusively on Minerva Neurosciences' fundamentals will not take into account other important factors: Minerva Neurosciences Company Current Valuation Analysis
Minerva Neurosciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Minerva Neurosciences Current Valuation | (11.49 M) |
Most of Minerva Neurosciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Minerva Neurosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Minerva Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Minerva Neurosciences is extremely important. It helps to project a fair market value of Minerva Stock properly, considering its historical fundamentals such as Current Valuation. Since Minerva Neurosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Minerva Neurosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Minerva Neurosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Minerva Neurosciences has a Current Valuation of (11.49 Million). This is 100.08% lower than that of the Biotechnology sector and 100.25% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.07% higher than that of the company.
Minerva Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Minerva Neurosciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Minerva Neurosciences could also be used in its relative valuation, which is a method of valuing Minerva Neurosciences by comparing valuation metrics of similar companies.Minerva Neurosciences is currently under evaluation in current valuation category among its peers.
Minerva Neurosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Minerva Neurosciences from analyzing Minerva Neurosciences' financial statements. These drivers represent accounts that assess Minerva Neurosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Minerva Neurosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 277.4M | 95.5M | 34.2M | 8.5M | 40.0M | 38.0M | |
| Enterprise Value | 256.3M | 70.3M | (26.5M) | 46.1M | 81.1M | 127.3M |
Minerva Neurosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Minerva Neurosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Minerva Neurosciences' managers, analysts, and investors.Environmental | Governance | Social |
Minerva Fundamentals
| Return On Equity | -6.75 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | (11.49 M) | ||||
| Shares Outstanding | 6.99 M | ||||
| Shares Owned By Insiders | 22.26 % | ||||
| Shares Owned By Institutions | 30.47 % | ||||
| Number Of Shares Shorted | 23.38 K | ||||
| Price To Earning | 69.58 X | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 1.87 X | ||||
| Gross Profit | (16.84 M) | ||||
| EBITDA | (21.69 M) | ||||
| Net Income | (30.01 M) | ||||
| Cash And Equivalents | 40.22 M | ||||
| Cash Per Share | 7.53 X | ||||
| Total Debt | 82.02 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 20.41 X | ||||
| Book Value Per Share | (3.10) X | ||||
| Cash Flow From Operations | (14.78 M) | ||||
| Short Ratio | 0.96 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Target Price | 5.0 | ||||
| Beta | 0.17 | ||||
| Market Capitalization | 15.04 M | ||||
| Total Asset | 56.9 M | ||||
| Retained Earnings | (396.82 M) | ||||
| Working Capital | 38.66 M | ||||
| Current Asset | 33.48 M | ||||
| Current Liabilities | 5.32 M | ||||
| Net Asset | 56.9 M |
About Minerva Neurosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Minerva Neurosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Minerva Neurosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Minerva Neurosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.